Perceptive Advisors Launches New Fund to Invest in Early Stage Companies
The life sciences specialist, whose assets have grown substantially over the past few years, now has three different strategies.
Perceptive Advisors has launched a new venture capital fund.
The health care-focused firm headed by Joseph Edelman disclosed in a regulatory filing that it has raised $200 million for the Perceptive Xontogeny Venture Fund and a related vehicle, Perceptive Xontogeny Venture SLP. Perceptive declined to comment.